Pacific Biosciences of California, Inc. (PACB)
1.35
+0.05
(+3.85%)
USD |
NASDAQ |
Sep 04, 16:00
1.345
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Research and Development Expense (Quarterly) : 23.02M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.02M |
| March 31, 2026 | 19.61M |
| December 31, 2025 | 22.88M |
| September 30, 2025 | 26.65M |
| June 30, 2025 | 18.73M |
| March 31, 2025 | 26.95M |
| December 31, 2024 | 27.47M |
| September 30, 2024 | 25.52M |
| June 30, 2024 | 32.58M |
| March 31, 2024 | 43.46M |
| December 31, 2023 | 44.54M |
| September 30, 2023 | 47.51M |
| June 30, 2023 | 46.17M |
| March 31, 2023 | 48.94M |
| December 31, 2022 | 42.62M |
| September 30, 2022 | 47.09M |
| June 30, 2022 | 50.35M |
| March 31, 2022 | 52.94M |
| December 31, 2021 | 42.58M |
| September 30, 2021 | 27.51M |
| June 30, 2021 | 22.27M |
| March 31, 2021 | 20.55M |
| December 31, 2020 | 17.42M |
| September 30, 2020 | 16.47M |
| June 30, 2020 | 15.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.25M |
| December 31, 2019 | 14.27M |
| September 30, 2019 | 14.96M |
| June 30, 2019 | 14.91M |
| March 31, 2019 | 15.48M |
| December 31, 2018 | 16.26M |
| September 30, 2018 | 14.36M |
| June 30, 2018 | 15.66M |
| March 31, 2018 | 16.31M |
| December 31, 2017 | 15.63M |
| September 30, 2017 | 15.84M |
| June 30, 2017 | 16.88M |
| March 31, 2017 | 16.97M |
| December 31, 2016 | 16.26M |
| September 30, 2016 | 17.48M |
| June 30, 2016 | 17.52M |
| March 31, 2016 | 16.36M |
| December 31, 2015 | 14.75M |
| September 30, 2015 | 16.16M |
| June 30, 2015 | 15.04M |
| March 31, 2015 | 14.48M |
| December 31, 2014 | 12.33M |
| September 30, 2014 | 11.69M |
| June 30, 2014 | 12.44M |
| March 31, 2014 | 11.77M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Illumina, Inc. | 257.00M |
| Danaher Corp. | 412.00M |
| Thermo Fisher Scientific, Inc. | 364.00M |
| Agilent Technologies, Inc. | 120.00M |
| Bio-Rad Laboratories, Inc. | 61.20M |